MarketPeel
Insider Trading Intelligence
Pricing
…
AD

Atul Dandekar

MAZE
CSBO · MAZE THERAPEUTICS, INC. · CIK 0002050167
FILING MIX · LIFETIME36%/64%
BUYS
13
SELLS
23
TOTAL VALUE
$5.80M
COMPANIES
1
ACTIVE SINCE
Sep 2025
HOLDINGS NOW
33,750
AVG SELL PX
$37.72
TRADE KIND
SHOWING 36 / 36
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 31 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Atul Dandekar, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+90.91%-1.91%+0.11%-2.02%-0.05%—
14d11+36.36%+2.68%+1.10%+1.58%+2.36%—
30d11+36.36%-5.72%+0.92%-7.47%+2.47%—
60d11+63.64%-14.70%-1.95%-13.98%-26.59%—
90d11(1 pending)+100.00%-30.17%+1.75%-28.91%-20.34%—
180d11(8 pending)+100.00%-29.60%+6.02%-35.62%-35.87%—
1y11(11 pending)——————
2y11(11 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MAZE · 33,750 shares · as of Jun 29, 2026
020,72641,45262,17782,9032026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2025
2026
2026
FLOW · 13 buys / 23 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,500$28.02$210.2K26,250Jun 29, 2026Jul 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
7,500$10.42$78.2K33,750Jun 29, 2026Jul 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
7,500——29,143Jun 29, 2026Jul 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
7,500$10.42$78.2K32,308May 29, 2026Jun 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
7,500——36,643May 29, 2026Jun 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,500$26.34$197.6K24,808May 29, 2026Jun 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
8,320$10.42$86.7K18,823May 4, 2026May 6, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
5,985$10.42$62.4K24,808May 4, 2026May 6, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
5,985——27,725May 4, 2026May 6, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
8,320——20,204May 4, 2026May 6, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,500$25.37$190.3K10,503Apr 29, 2026May 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
7,500$10.42$78.2K18,003Apr 29, 2026May 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
7,500——44,143Apr 29, 2026May 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
790$30.02$23.7K10,503Mar 30, 2026Apr 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
7,500——51,643Mar 30, 2026Apr 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
7,500$10.42$78.2K18,003Mar 30, 2026Apr 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,710$29.26$196.3K11,293Mar 30, 2026Apr 1, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,000——19,000Mar 2, 2026Mar 3, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,000——38,000Mar 2, 2026Mar 3, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
7,500$10.42$78.2K18,003Feb 27, 2026Mar 3, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
7,500——59,143Feb 27, 2026Mar 3, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,761$45.72$172.0K10,503Feb 27, 2026Mar 3, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,739$45.13$168.8K14,264Feb 27, 2026Mar 3, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,800$45.01$126.0K10,503Jan 29, 2026Feb 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,200$43.18$51.8K16,803Jan 29, 2026Feb 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,500$44.04$154.1K13,303Jan 29, 2026Feb 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
7,500——66,643Jan 29, 2026Feb 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
7,500$10.42$78.2K18,003Jan 29, 2026Feb 2, 2026 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
100——74,143Dec 30, 2025Dec 31, 2025 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$40.36$4.0K10,503Dec 30, 2025Dec 31, 2025 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
100$10.42$1.0K10,603Dec 30, 2025Dec 31, 2025 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
66,365$40.51$2.69M16,538Dec 29, 2025Dec 31, 2025 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASE
CSBO
72,400$10.42$754.4K82,903Dec 29, 2025Dec 31, 2025 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,035$41.13$248.2K10,503Dec 29, 2025Dec 31, 2025 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
SALE
CSBO
72,400——74,243Dec 29, 2025Dec 31, 2025 ↗View →
MAZE
MAZE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,000——25,000Sep 22, 2025Sep 24, 2025 ↗View →
Other insiders · MAZE
Loading peer insiders…
About this filer
CIK 0002050167
ROLE
CSBO
PRIMARY
MAZE
COMPANIES
1
ACTIVE SINCE
Sep 2025
MARKETPEEL · /INSIDER/0002050167DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback